MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

Search

Minerva Neurosciences Inc

Închisă

1.63 -1.81

Rezumat

Modificarea prețului

24h

Curent

Minim

1.59

Maxim

1.66

Indicatori cheie

By Trading Economics

P/E

Medie Sector

1.843

39.564

EPS

-0.5

Angajați

8

Dividende

By Dow Jones

Următoarele câștiguri

5 aug. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

1.3M

9.6M

Deschiderea anterioară

3.44

Închiderea anterioară

1.63

Minerva Neurosciences Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

9 iul. 2025, 15:46 UTC

Principalele dinamici ale pieței

BitMine Shares Fall After Closing of $250 Million Private Placement

9 iul. 2025, 23:44 UTC

Market Talk

Gold Edges Higher Amid U.S. Tariff Concerns -- Market Talk

9 iul. 2025, 23:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

9 iul. 2025, 23:42 UTC

Market Talk

Nikkei May Trade Rangebound as U.S. Tariff Uncertainty Continues -- Market Talk

9 iul. 2025, 22:59 UTC

Market Talk

Reliance Worldwide's Costs at Risk From Copper Tariffs -- Market Talk

9 iul. 2025, 22:59 UTC

Market Talk

Global Equities Roundup: Market Talk

9 iul. 2025, 20:50 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Health Care Roundup: Market Talk

9 iul. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

9 iul. 2025, 20:26 UTC

Câștiguri

Nvidia Is the Most Valuable Company Ever. Why $5 Trillion Could Be Next. -- Barrons.com

9 iul. 2025, 19:18 UTC

Market Talk

Oil Futures End Little Changed After Big U.S. Crude Stock Build -- Market Talk

9 iul. 2025, 19:03 UTC

Market Talk

U.S. Natural Gas Posts Back-to-Back Losses -- Market Talk

9 iul. 2025, 18:31 UTC

Market Talk

Some Fed Officials Supported Considering July Cut -- Market Talk

9 iul. 2025, 17:07 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Honeywell's Streamlining Efforts Clear Path for Stock to Catch Up -- Market Talk

9 iul. 2025, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk -2-

9 iul. 2025, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

9 iul. 2025, 16:20 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Health Care Roundup: Market Talk

9 iul. 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

9 iul. 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

9 iul. 2025, 16:14 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

9 iul. 2025, 16:14 UTC

Market Talk

Rents in Canada Soften For Ninth-Straight Month -- Market Talk

9 iul. 2025, 16:14 UTC

Achiziții, Fuziuni, Preluări

Apple Has Dropped the Ball on AI. Buying Perplexity Could Help It Catch Up, Say Analysts. -- Barrons.com

9 iul. 2025, 16:12 UTC

Market Talk

Gold Futures Broadly Flat in Largely Directionless Trade -- Market Talk

9 iul. 2025, 16:08 UTC

Market Talk

Oil Ticks Higher Amid Large U.S. Crude Build, Red Sea Tensions, Tariff Uncertainty -- Market Talk

9 iul. 2025, 15:31 UTC

Principalele dinamici ale pieței

BitMine Shares Fall After Closing of $250M Private Placement

9 iul. 2025, 15:31 UTC

Market Talk
Achiziții, Fuziuni, Preluări

With Competing Bids Unlikely, Merck's Path to Acquiring Verona Looks Smooth -- Market Talk

9 iul. 2025, 15:27 UTC

Market Talk

Copper Rally Expected to Fade Amid Tepid Global Demand -- Market Talk

9 iul. 2025, 14:36 UTC

Achiziții, Fuziuni, Preluări

Merck to Buy Verona Pharma in $10 Billion Deal -- 2nd Update

9 iul. 2025, 14:31 UTC

Achiziții, Fuziuni, Preluări

Meta Has Surged on the Back of AI Software. Why Hardware Is the Next Play. -- Barrons.com

9 iul. 2025, 14:26 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

9 iul. 2025, 14:26 UTC

Market Talk

Aug 1 Tariffs Will Boost Average Rate Near 15%, JPMorgan Estimates -- Market Talk

Comparație

Modificare preț

Minerva Neurosciences Inc Așteptări

Consens privind evaluarea

By TipRanks

0 ratings

0

Cumpărare

0

Păstrare

0

Vânzare

Date financiare

$

Despre Minerva Neurosciences Inc

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone (MIN-101) for the treatment of negative symptoms in patients with schizophrenia, currently submitted an New Drug Application (NDA); and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. The company has a license agreement with Mitsubishi Tanabe Pharma Corporation to develop, sell, and import roluperidone globally excluding Asia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.